Literature DB >> 18424353

The -1131T>C polymorphism in the apolipoprotein A5 gene is related to hypertriglyceridemia in Taiwanese aborigines.

Meng-Chuan Huang1, Tsu-Nai Wang, Huan-Sen Wang, Yi-Ching Sung, Ying-Chin Ko, Hung-Che Chiang.   

Abstract

The prevalence of hypertriglyceridemia, considered to be an independent risk factor for the development of cardiovascular disease, is high in Taiwanese aborigines. This study was undertaken to examine the effect of the -1131T>C polymorphism in the apolipoprotein A5 gene on serum triglyceride levels in female Taiwanese aborigines. This was a cross-sectional study, and a total of 316 unrelated female Taiwanese aborigines were genotyped at the -1131T>C polymorphism in apolipoprotein A5 using the polymerase chain reaction-restriction fragment length polymorphism method. Serum triglyceride > or = 150 mg/dL was defined as the hypertriglyceridemia group and triglyceride < 150 mg/dL was considered to be the control group. The frequency of the minor C allele was significantly higher in the hypertriglyceridemia group (0.53) than in the control group (0.35) (p < 0.001). The frequency of this rare allele was comparable to that in Japanese and Han Chinese, but was higher than that in Caucasians. In a multiple logistic model adjusted for possible confounders, C allele-containing variants were independently associated with greater risks (CT genotype: OR = 3.28, 95% CI = 1.43-7.56; CC genotype: OR = 5.86, 95% CI = 2.15-15.99) of hypertriglyceridemia than the TT genotype (p < 0.01), notably with the CC homozygote exhibiting the greatest risks. The genotype polymorphisms were also associated with serum triglyceride concentrations in a linear fashion (for trend, p < 0.05). Our results indicate that the -1131T>C polymorphism of the Apo A5 gene influences serum triglyceride levels in female Taiwanese aborigines, and that differences exist in the frequency of the C allele among people of various ethnicities.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18424353     DOI: 10.1016/S1607-551X(08)70114-1

Source DB:  PubMed          Journal:  Kaohsiung J Med Sci        ISSN: 1607-551X            Impact factor:   2.744


  7 in total

1.  Association of APOA5 Gene Promoter Region -1131T>C Polymorphism (rs662799) to Plasma Triglyceride Level in Patients with Type 2 Diabetic Nephropathy.

Authors:  Abdolkarim Mahrooz; Mehryar Zargari; Vahid Ansari; Atieh Makhlough; Mohammad-Bagher Hashemi-Sooteh
Journal:  J Clin Diagn Res       Date:  2016-05-01

2.  Apolipoprotein A5 polymorphisms in Turkish population: association with serum lipid profile and risk of ischemic stroke.

Authors:  Birsen Can Demirdöğen; Esra Şahin; Aysun Türkanoğlu Özçelik; Semai Bek; Şeref Demirkaya; Orhan Adali
Journal:  Mol Biol Rep       Date:  2012-10-13       Impact factor: 2.316

3.  Association of the apolipoprotein A5 gene -1131 T>C polymorphism with fasting blood lipids: a meta-analysis in 37859 subjects.

Authors:  Tongfeng Zhao; Jiangpei Zhao
Journal:  BMC Med Genet       Date:  2010-08-10       Impact factor: 2.103

4.  Interactions of the apolipoprotein A5 gene polymorphisms and alcohol consumption on serum lipid levels.

Authors:  Rui-Xing Yin; Yi-Yang Li; Wan-Ying Liu; Lin Zhang; Jin-Zhen Wu
Journal:  PLoS One       Date:  2011-03-14       Impact factor: 3.240

5.  Association between apolipoprotein gene polymorphisms and hyperlipidemia: a meta-analysis.

Authors:  Xiao-Ning Zhao; Quan Sun; You-Qin Cao; Xiao Ran; Yu Cao
Journal:  BMC Genom Data       Date:  2021-04-09

6.  Effects of APOA5 -1131T>C (rs662799) on fasting plasma lipids and risk of metabolic syndrome: evidence from a case-control study in China and a meta-analysis.

Authors:  Chunxiao Xu; Rongpan Bai; Dandan Zhang; Zhenli Li; Honghong Zhu; Maode Lai; Yimin Zhu
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

7.  Association of two common polymorphisms of apolipoprotein A5 gene with metabolic syndrome indicators in a North Iranian population, a cross-sectional study.

Authors:  Sohrab Halalkhor; Farzad Jalali; Karimollah Hajian Tilaki; Shahla Shojaei
Journal:  J Diabetes Metab Disord       Date:  2014-04-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.